a company which engages in development of novel recombinant vaccines
Industry Biotechnology
A.I.dvisor indicates that over the last year, NVAX has been loosely correlated with ITOS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if NVAX jumps, then ITOS could also see price increases.
Ticker / NAME | Correlation To NVAX | 1D Price Change % | ||
---|---|---|---|---|
NVAX | 100% | -8.22% | ||
ITOS - NVAX | 39% Loosely correlated | -3.92% | ||
ADMA - NVAX | 35% Loosely correlated | -1.42% | ||
PPTDF - NVAX | 32% Poorly correlated | N/A | ||
RXRX - NVAX | 32% Poorly correlated | -3.43% | ||
ARCT - NVAX | 31% Poorly correlated | -2.04% | ||
More |
Ticker / NAME | Correlation To NVAX | 1D Price Change % |
---|---|---|
NVAX | 100% | -8.22% |
covid-19 vaccine theme (6 stocks) | 36% Loosely correlated | -3.27% |
drugs theme (254 stocks) | 25% Poorly correlated | -1.72% |
biotechnology theme (238 stocks) | 18% Poorly correlated | -1.80% |
vaccines theme (15 stocks) | 13% Poorly correlated | -5.05% |